Article
Structure-based mutational analysis of ICAT residues mediating negative regulation of β-catenin co-transcriptional activity.
PloS one - 1 Jan 2017
Domingues Mélanie J, Martinez-Sanz Juan, Papon Laura, Larue Lionel, Mouawad Liliane, Bonaventure Jacky
Abstract excerpt
ICAT (Inhibitor of β-CAtenin and TCF) is a small acidic protein that negatively regulates β-catenin co-transcriptional activity by competing with TCF/LEF factors in their binding to β-catenin superhelical core. In melanoma cells, ICAT competes with LEF1 to negatively regulate the M-MITF and NEDD9 target genes. The structure of ICAT consists of two domains: the 3-helix bundle N-terminal domain binds to β-catenin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
